Home LiteratureArticle Details
PMID: 1682653 Published · ppublish English Clinical Trial Comparative Study Journal Article Research Support, Non-U.S. Gov't

One week eradication regimen for Helicobacter pylori.

Lancet (London, England) ·Vol. 338 ·No. 8777 ·1991-11-16 ·Pages 1249-52

Logan RP, Gummett PA, Misiewicz JJ, Karim QN, Walker MM, Baron JH

Abstract

Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori, were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9.3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.

MeSH Terms
Adolescent Adult Aged Aged, 80 and over Algorithms Amoxicillin/administration & dosage Anti-Ulcer Agents/administration & dosage Drug Administration Schedule Drug Combinations Drug Resistance, Microbial Female Follow-Up Studies Helicobacter Infections/diagnosis,drug therapy Helicobacter pylori/drug effects,isolation & purification Humans Male Metronidazole/administration & dosage Middle Aged Organometallic Compounds/administration & dosage Patient Compliance Pyloric Antrum/microbiology Time Factors
Chemicals
Anti-Ulcer Agents Drug Combinations Organometallic Compounds Metronidazole Amoxicillin bismuth tripotassium dicitrate
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Logan R P
Parkside Helicobacter Study Group, Central Middlesex Hospital, London, UK.
Gummett P A
Misiewicz J J
Karim Q N
Walker M M
Baron J H
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1991-11-16
Pages
1249-52
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentIn
CommentIn
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com